Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-07-10. The company specializes in stabilizing carbohydrate molecules. The company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two advanced programs are the cosmetic skin lightener and diabetes drug. Other projects include the development of an anti-aging / cell protection library, a novel anti-wrinkle compound, and the launch of an anti-viral program. Its TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. The company is focused on three antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its subsidiary is TFChem S.A.R.L.
Follow-Up Questions
Sirona Biochem Corp 'in CEO'su kimdir?
Dr. Howard Y 2020 'den beri şirketle birlikte olan Sirona Biochem Corp 'in Chairman of the Board 'ıdır.
SRBCF hissesinin fiyat performansı nasıl?
SRBCF 'in mevcut fiyatı $0.0103 'dir, son işlem günde 0% decreased etti.
Sirona Biochem Corp için ana iş temaları veya sektörler nelerdir?
Sirona Biochem Corp Biotechnology endüstrisine ait ve sektör Health Care 'dir
Sirona Biochem Corp 'in piyasa değerlemesi nedir?
Sirona Biochem Corp 'in mevcut piyasa değerlemesi $0 'dir
Sirona Biochem Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Sirona Biochem Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 5 al, 1 tut, 0 sat ve 3 güçlü sat içermektedir
